Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2

Journal of the American College of Cardiology

Volumn 45, Issue 10, 2005, Pages 1707-1715

  Jiang, Xiaojing ^a   Shi, Enyi ^a   Nakajima, Yoshiki ^a   Sato, Shigehito ^a   Ohno, Koji ^a   Yue, Hui ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MORPHINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME IMMUNOASSAY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CARDIOTONIC AGENTS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; INDOMETHACIN; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MORPHINE; MYOCARDIAL INFARCTION; MYOCARDIUM; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SULFONAMIDES; TIME FACTORS; UP-REGULATION;

EID: 18944368858     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.02.046     Document Type: Article

References (41)

1. C.E. Murry, R.B. Jennings, K.A. Reimer Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
2. X.L. Tang, Y. Qiu, S.W. Park, J.Z. Sun, A. Kalya, R. Bolli Time course of late preconditioning against myocardial stunning in conscious pigs Circ Res 79 1996 424 434
3. Y. Wang, E. Kodani, J. Wang Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2 Circ Res 95 2004 84 91
4. J.J. Schultz, A.K. Hsu, G.J. Gross Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart Circ Res 78 1996 1100 1104
5. H.H. Patel, R.M. Fryer, E.R. Gross 12-lipoxygenase in opioid-induced delayed cardioprotection gene array, mass spectrometric, and pharmacological analyses Circ Res 92 2003 676 682
6. K. Shinmura, M. Nagai, K. Tamaki, M. Tani, R. Bolli COX2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts Am J Physiol Heart Circ Physiol 283 2002 H2534 H2543
7. R.M. Fryer, A.K. Hsu, J.T. Eells, H. Nagase, G.J. Gross Opioid-induced second window of cardioprotection potential role of mitochondrial KATP channels Circ Res 84 1999 846 851
8. E. Shi, X. Jiang, H. Bai, T. Gu, Y. Chang, J. Wang Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion Chin Med J (Engl) 116 2003 1059 1062
9. L.M. Ludwig, H.H. Patel, G.J. Gross, J.R. Kersten, P.S. Pagel, D.C. Warltier Morphine enhances pharmacological preconditioning by isoflurane role of mitochondrial K(ATP) channels and opioid receptors Anesthesiology 98 2003 705 711
10. X. Jiang, E. Shi, Y. Nakajima, S. Sato Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo evidence from pharmacologic inhibition and gene-knockout mice Anesthesiology 101 2004 82 88
11. K. Shinmura, X.L. Tang, Y. Wang Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits Proc Natl Acad Sci USA 97 2000 10197 10202
12. K. Shinmura, Y.T. Xuan, X.L. Tang Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning Circ Res 90 2002 602 608
13. Y. Guo, W. Bao, W.J. Wu, K. Shinmura, X.L. Tang, R. Bolli Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice Basic Res Cardiol 95 2000 479 484
14. Y.T. Xuan, Y. Guo, Y. Zhu Mechanism of cyclooxygenase-2 upregulation in late preconditioning J Mol Cell Cardiol 35 2003 525 537
15. C. Arnaud, M. Joyeux-Faure, D. Godin-Ribuot, C. Ribuot COX-2 an in vivo evidence of its participation in heat stress-induced myocardial preconditioning Cardiovasc Res 58 2003 582 588
16. K. Tanaka, L.M. Ludwig, J.G. Krolikowski Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury role of cyclooxygenase-2 Anesthesiology 100 2004 525 531
17. E. Kodani, Y.T. Xuan, K. Shinmura, H. Takano, X.L. Tang, R. Bolli Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits Am J Physiol Heart Circ Physiol 283 2002 H1943 H1957
18. H.H. Patel, A.K. Hsu, G.J. Gross COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat Life Sci 75 2004 129 140
19. E. Kodani, K. Shinmura, Y.T. Xuan Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors Am J Physiol Heart Circ Physiol 281 2001 H959 H968
20. R. Pajdo, T. Brzozowski, P.C. Konturek Ischemic preconditioning, the most effective gastroprotective intervention involvement of prostaglandins, nitric oxide, adenosine and sensory nerves Eur J Pharmacol 427 2001 263 276
21. T. Brzozowski, P.C. Konturek, S.J. Konturek Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves Eur J Pharmacol 499 2004 201 213
22. M.G. Camitta, S.A. Gabel, P. Chulada Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning Circulation 104 2001 2453 2458
23. N.P. Dowd, M. Scully, S.R. Adderley, A.J. Cunningham, D.J. Fitzgerald Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo J Clin Invest 108 2001 585 590
24. P. Ping, J. Zhang, Y. Qiu Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity Circ Res 81 1997 404 414
25. I. Morita, M. Schindler, M.K. Regier Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2 J Biol Chem 270 1995 10902 10908
26. A.G. Spencer, J.W. Woods, T. Arakawa, I.I. Singer, W.L. Smith Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy J Biol Chem 273 1998 9886 9893
27. W.R. Martin Pharmacology of opioids Pharmacol Rev 35 1983 283 323
28. G.F. Baxter, F.M. Goma, D.M. Yellon Characterisation of the infarct-limiting effect of delayed preconditioning time course and dose-dependency studies in rabbit myocardium Basic Res Cardiol 92 1997 159 167
29. W.L. Smith, R.M. Garavito, D.L. DeWitt Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 J Biol Chem 271 1996 33157 33160
30. J.R. Vane, Y.S. Bakhle, R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97 120
31. L. Xi, D. Tekin, E. Gursoy, F. Salloum, J.E. Levasseur, R.C. Kukreja Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia Am J Physiol Heart Circ Physiol 283 2002 H5 H12
32. H. Darius, T. Thomsen, K. Schror Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist J Cardiovasc Pharmacol 10 1987 144 152
33. P.J. Simpson, S.E. Mitsos, A. Ventura Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation Am Heart J 113 1987 129 137
34. C.Y. Xiao, K. Yuhki, A. Hara, T. Fujino, S. Kuriyama, T. Yamada Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4 Circulation 109 2004 2462 2468
35. B.I. Jugdutt, G.M. Hutchins, B.H. Bulkley, L.C. Becker Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs Circ Res 49 1981 685 700
36. P. Gres, R. Schulz, J. Jansen, C. Umschlag, G. Heusch Involvement of endogenous prostaglandins in ischemic preconditioning in pigs Cardiovasc Res 55 2002 626 632
37. A. Jalowy, R. Schulz, H. Dorge, M. Behrends, G. Heusch Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs J Am Coll Cardiol 32 1998 1787 1796
38. J.F. Bouchard, E. Dumont, D. Lamontagne Evidence that prostaglandins I2, E2, and D2 may activate ATP sensitive potassium channels in the isolated rat heart Cardiovasc Res 28 1994 901 905
39. N. Nakhostine, D. Lamontagne Contribution of prostaglandins in hypoxia-induced vasodilation in isolated rabbit hearts. Relation to adenosine and KATP channels Pfluger's Arch 428 1994 526 532
40. B.C. McPherson, Z. Yao Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes Circulation 103 2001 290 295
41. Z. Cao, L. Liu, D.M. Van Winkle Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels Am J Physiol Heart Circ Physiol 285 2003 H1032 H1039